Affordable Access

Addition of rosiglitazone to existing sulfonylurea treatment in chinese patients with type 2 diabetes and exposure to hepatitis B or C.

Authors
Type
Published Article
Journal
Diabetes technology & therapeutics
Publication Date
Volume
5
Issue
1
Pages
33–42
Identifiers
PMID: 12725705
Source
Medline

Abstract

Statistics

Seen <100 times